$3.03 -0.08 (-2.57%)
2/10/2012 4:00 PM

Orexigen Therapeutics, Inc. (NASDAQ:OREX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Featured Broker Partners


Advertisement